TKT与DERA基因变异预测皮肤黑色素瘤生存
研究基于MDACC的858例皮肤黑色素瘤患者GWAS数据,分析134个NADPH相关基因的10,912个SNP与生存的关联,并在NHS/HPFS的409例中验证。Meta分析发现TKT rs9864057与DERA rs12297652独立关联黑色素瘤特异性生存,风险等位基因累积与死亡风险升高相关,且与皮肤mRNA表达升高相关。
要点
- TKT rs9864057与DERA rs12297652独立关联黑色素瘤特异性生存。
- 两SNP风险等位基因累积增加与死亡风险升高呈剂量效应。
- 两SNP与日晒下肢皮肤mRNA表达升高相关,可能为功能变异。
核心结论
- TKT rs9864057与DERA rs12297652可能是皮肤黑色素瘤生存的有价值预后生物标志物,但需更大研究验证。
研究设计与样本
- 单中心GWAS单基因座分析纳入MDACC的858例皮肤黑色素瘤患者,检测134个NADPH相关基因的10,912个SNP(2018个基因分型、8894个插补)。
- 在NHS/HPFS的409例皮肤黑色素瘤患者GWAS数据集中进行重复验证。
主要发现
- MDACC队列858例中95例(11.1%)死于黑色素瘤,NHS/HPFS队列409例中48例(11.7%)死于黑色素瘤。
- 多变量Cox回归Meta分析显示TKT rs9864057 G>A与黑色素瘤特异性生存显著关联,HR=1.52(95%CI 1.18-1.96,P=1.06×10^-3)。
- DERA rs12297652 A>G与黑色素瘤特异性生存显著关联,HR=1.51(95%CI 1.19-1.91,P=5.89×10^-4)。
- 两SNP风险基因型数量增加与死亡风险升高相关,MDACC、NHS/HPFS及合并数据集的Ptrend分别为<0.001、0.004和<0.001。
- 表达数量性状位点分析显示TKT rs9864057 G>A与DERA rs12297652 A>G分别与日晒下肢皮肤mRNA表达升高显著相关(P=0.043和0.006)。
临床怎么用
- 可考虑将TKT rs9864057与DERA rs12297652作为皮肤黑色素瘤生存预后评估的候选生物标志物,但尚需更大样本验证后方可用于临床决策。
局限性
- 原文结论指出需要更大规模的研究来验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cutaneous melanoma (CM) is the most lethal type of skin cancers. Nicotinamide adenine dinucleotide phosphate (NADPH) plays an important role in anabolic reactions and tumorigenesis, but many genes are involved in the NADPH system. METHODS: We used 10,912 single-nucleotide polymorphisms (SNPs) (2018 genotyped and 8894 imputed) in 134 NADPH-related genes from a genome-wide association study (GWAS) of 858 patients from The University of Texas MD Anderson Cancer Center (MDACC) in a single-locus analysis to predict CM survival. We then replicated the results in another GWAS data set of 409 patients from the Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS). RESULTS: There were 95 of 858 (11.1%) and 48 of 409 (11.7%) patients who died of CM, respectively. In multivariable Cox regression analyses, we identified two independent SNPs (TKT rs9864057 G > A and deoxyribose phosphate aldolase (DERA) rs12297652 A > G) to be significantly associated with CM-specific survival [hazards ratio (HR) of 1.52, 95% confidence interval (CI) = 1.18-1.96, P = 1.06 × 10-3 and 1.51 (1.19-1.91, 5.89 × 10-4)] in the meta-analysis, respectively. Furthermore, an increasing number of risk genotypes of these two SNPs was associated with a higher risk of death in the MDACC, the NHS/HPFS, and their combined data sets (Ptrend<0.001, = 0.004 and <0.001, respectively). In the expression quantitative trait loci analysis, TKT rs9864057 G > A and DERA rs12297652 A > G were also significantly associated with higher mRNA expression levels in sun-exposed lower-leg skin (P = 0.043 and 0.006, respectively). CONCLUSIONS: These results suggest that these two potentially functional SNPs may be valuable prognostic biomarkers for CM survival, but larger studies are needed to validate these findings.
引用
- Gu N, Dai W, Liu H, et al. Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival. Eur J Cancer. 2020. PMID: 32659474. doi:10.1016/j.ejca.2020.04.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。